Posted inBusiness
J&J beats quarterly sales and profit estimates on cancer drug sales
By Patrick Wingrove and Bhanvi Satija (Reuters) - Johnson & Johnson (JNJ), fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular, reported fourth-quarter sales and profit above Wall…